Health Care & Life Sciences » Pharmaceuticals | Guizhou Bailing Group Pharmaceutical Co. Ltd.

Guizhou Bailing Group Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Guizhou Bailing Group Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
943,359
0.17%
-51,800
0.64%
12/31/2017
Huatai - PineBridge CSI 300 ETF Units
741,474
0.14%
-47,600
0.04%
12/31/2017
China SME ETF
685,016
0.13%
-5,200
0.35%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
681,807
0.13%
0
0%
07/31/2018
China AMC CSI 300 Index ETF (CN)
662,121
0.12%
-16,800
0.04%
12/31/2017
Harvest SZSE SME-CHINEXT 300 ETF
654,528
0.12%
-58,300
0.04%
12/31/2017
ChinaAMC ETF Series - CSI 300 Index ETF
393,142
0.07%
-11,800
0.05%
12/31/2017
296,907
0.05%
43,900
0.88%
12/31/2017
256,375
0.05%
24,400
0.28%
12/31/2017
244,640
0.05%
-60,200
0.33%
12/31/2017

About Guizhou Bailing Group Pharmaceutical Co.

View Profile
Address
Xihang Avenue
Anshun Guizhou 561000
China
Employees -
Website http://www.gzbl.com
Updated 07/08/2019
Guizhou Bailing Group Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicines. It offers medicines in the form of tablets, capsules, syrups, soft capsules, granules, pills, powder, sprays, creams, and injections. Its products are used for treatment of cardiovascular and cerebrovascular diseases, cough, common cold, and fever.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.